Blend-specific informed consent for the most-prescribed GH peptide combination, current to the 2023-24 FDA compounding review.
$15 — opening soon on this site and on Etsy.
Every document: editable placeholders for your practice name and providers · US Letter + A4 · educational-template disclaimer included.
The complete documentation system for peptide practices: five substance-specific informed consents (BPC-157, CJC-1295/Ipamorelin, Sermorelin, NAD+, Glutathione), peptide-specific intake, good-faith exam, chart notes, telehealth consent, full HIPAA pack, patient bill of rights and an adverse-event protocol..
Substance-specific informed consent for NAD+ injections and infusions — including rate-dependent infusion reactions and honest compounded-medication language..
An honest, thorough BPC-157 consent: investigational status, FDA compounding category history, unknown long-term effects — the disclosure serious clinics actually need..